Loading...
Thumbnail Image
Publication

Pregnancy Outcomes of Women Veterans with Autoimmune Disease

Sims, Catherine A
Cintron, Dahima
Wallace, Kate
Kroll-Desrosiers, Aimee
Shah, Ankoor
Gierisch, Jennifer M
Goldstein, Karen M
Mattocks, Kristin
Embargo Expiration Date
Abstract

BACKGROUND/OBJECTIVE: Women Veterans (WV) are exposed to unique risk factors for the development of autoimmune diseases (AID), which can increase risk of pregnancy complications. To characterize pregnancy outcomes in this population, our team performed a descriptive case series.

METHODS: To identify WV with AID from the Center for Maternal and Infant Outcomes Research in Translation dataset, medical records were screened using diagnostic codes and medications. A protocolized chart review and extraction was performed.

RESULTS: Twenty-five WV with AID were identified. The most frequently reported AID were inflammatory bowel disease ( = 4), psoriasis ( = 4), and undifferentiated connective tissue disease ( = 4). Forty-four percent of WV with AID experienced pregnancy complications, 32% utilized VA subspecialty care for AID management, and 40% did not seek health care at the VA during their pregnancy.

CONCLUSIONS: Identified pregnancies had a high frequency of complications with more than one in three Veterans lost to VA follow-up during pregnancy.

Source

Sims CA, Cintron D, Wallace K, Kroll-Desrosiers A, Shah A, Gierisch JM, Goldstein KM, Mattocks K. Pregnancy Outcomes of Women Veterans with Autoimmune Disease. Womens Health Rep (New Rochelle). 2024 Sep 6;5(1):650-657. doi: 10.1089/whr.2024.0078. PMID: 39391789; PMCID: PMC11462423.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1089/whr.2024.0078
PubMed ID
39391789
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Copyright The Author(s) 2024. Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.